{'fraction_non_alphanumeric': 0.024079320113314446, 'fraction_numerical': 0.0028328611898017, 'mean_word_length': 4.891666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Development and initial testing of a new tool to measure the experience of eczema control in adults and children

Eczema (also known as atopic eczema and atopic dermatitis) affects about one in five children and one in 10 adults. Asking patients to self‐report their ‘eczema control’ has been suggested as a way to measure the effect of eczema treatments over the long‐term. This study aimed to develop a tool (method) to measure ‘eczema control’ that can be filled in by eczema patients or their caregivers. Eczema control is a term that incorporates a range of factors, such as changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning.